Osteoarticular Tumor Characterization by Advanced Imaging
NCT ID: NCT02895633
Last Updated: 2016-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1090 participants
INTERVENTIONAL
2009-11-30
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary purposes are:
* to determine a possible correlation between some parameters and the histological grade (FNCLCC)
* to suggest a coherent diagnostic imaging approach for osteoarticular tumors.
The ancillary study will enroll patients needing radiological tumor follow-up. The purpose is to identify tools for evaluation of tumor activity and therapeutic response before modification of morpho-volumetric data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
NCT04394052
Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics
NCT05369689
Usefulness of Non EPI-DWI-MRI / CT 3D Static Co-registration Prior to Surgery of Cholesteatomas
NCT02903550
Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis
NCT06244420
Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care
NCT04486820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Histologic analysis will be used as a gold standard.
The following imaging techniques will be evaluated:
* contrast enhanced ultrasonography
* Low dose CT perfusion
* Magnetic resonance perfusion
* Diffusion weighted imaging
* Magnetic resonance proton spectroscopy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with bone or peripheral soft-tissue tumor
Ecography
Standard Doppler ultrasound and perfusion imaging after injection of Sonovue
CT scan
With injection of Iomeron 400
MRI
With injection of gadolinium (Multihance)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ecography
Standard Doppler ultrasound and perfusion imaging after injection of Sonovue
CT scan
With injection of Iomeron 400
MRI
With injection of gadolinium (Multihance)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with normal awareness level
* patients having signed informed consent
Exclusion Criteria
* persons deprived of liberty
* persons under legal protection or unable to give informed consent
* persons in life-threatening emergency
* allergy to Sonovue, iodinated contrast media or gadolinium chelates
* risk of pregnancy
* breastfeeding women
* acute coronary syndrome or unstable ischemic cardiopathy (ban on injection of contrast agent for CT scan)
* renal failure (ban on injection of contrast agent for MRI and CT scan)
* contraindication to MRI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro Augusto GONDIM TEIXEIRA
Role: PRINCIPAL_INVESTIGATOR
Service d'Imagerie Guilloz, CHRU Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service d'Imagerie Guilloz, CHRU Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Ribeiro GJ, Gillet R, Hossu G, Trinh JM, Euxibie E, Sirveaux F, Blum A, Teixeira PAG. Solitary bone tumor imaging reporting and data system (BTI-RADS): initial assessment of a systematic imaging evaluation and comprehensive reporting method. Eur Radiol. 2021 Oct;31(10):7637-7652. doi: 10.1007/s00330-021-07745-9. Epub 2021 Mar 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A00758-49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.